Green Cross Lab Cell Corporation (144510) — Cash Flow Reinvestment Rate
Green Cross Lab Cell Corporation (144510) has a Cash Flow Reinvestment Rate of 13.65x as of June 2026, reinvesting ₩2.84 Billion (capex ₩2.84 Billion ) from operating cash flow of ₩208.25 Million. See Green Cross Lab Cell Corporation (144510) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Green Cross Lab Cell Corporation Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Green Cross Lab Cell Corporation across 10 annual periods. For the full cash flow conversion analysis, see Green Cross Lab Cell Corporation (144510) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Green Cross Lab Cell Corporation (2015–2025)
Year-by-year capital reinvestment analysis for Green Cross Lab Cell Corporation. See Green Cross Lab Cell Corporation financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | ₩6.70 Billion | ₩9.19 Billion | ₩6.47 Billion | ▼ -50.3% |
| 2024 | 1.47x | ₩16.65 Billion | ₩11.34 Billion | ₩6.03 Billion | ▼ -89.8% |
| 2023 | 14.36x | ₩52.70 Billion | ₩3.67 Billion | ₩18.40 Billion | ▲ +2799.7% |
| 2022 | 0.50x | ₩32.88 Billion | ₩66.42 Billion | ₩6.91 Billion | ▼ -60.5% |
| 2021 | 1.25x | ₩29.96 Billion | ₩23.91 Billion | ₩10.88 Billion | ▼ -16.0% |
| 2020 | 1.49x | ₩13.57 Billion | ₩9.09 Billion | ₩4.79 Billion | ▼ -96.1% |
| 2019 | 38.67x | ₩8.62 Billion | ₩223.04 Million | ₩5.34 Billion | ▲ +84.7% |
| 2018 | 20.94x | ₩10.28 Billion | ₩490.92 Million | ₩4.78 Billion | ▲ +47.9% |
| 2017 | 14.16x | ₩40.51 Billion | ₩2.86 Billion | ₩1.78 Billion | ▲ +1115.2% |
| 2015 | 1.17x | ₩1.73 Billion | ₩1.49 Billion | ₩833.86 Million | — |